According to our (Global Info Research) latest study, the global Sodium Cromoglicate API market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.
Sodium Cromoglycate API belongs to the class of medications called mast cell stabilizers. It is used to prevent symptoms associated with asthma that are caused by exposure to certain substances or conditions. When used regularly, this medication will decrease the occurrence and severity of asthma attacks by reducing lung inflammation.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report is a detailed and comprehensive analysis for global Sodium Cromoglicate API market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Sodium Cromoglicate API market size and forecasts, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2020-2031
Global Sodium Cromoglicate API market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2020-2031
Global Sodium Cromoglicate API market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2020-2031
Global Sodium Cromoglicate API market shares of main players, shipments in revenue ($ Million), sales quantity (Tons), and ASP (US$/Ton), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Sodium Cromoglicate API
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Sodium Cromoglicate API market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Cambrex, LGM Pharma, JSN Chemicals, DEAFARMA, Sanofi Active Ingredient Solutions, Fermion Oy, P&R SpA, SIMS Srl, Egis Pharmaceuticals PLC, Xian Hench Biotechnology, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Sodium Cromoglicate API market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Abrove Purity 98%
Purity 99%
Market segment by Application
Pharmaceutical Industry
Research Organization
Others
Major players covered
Cambrex
LGM Pharma
JSN Chemicals
DEAFARMA
Sanofi Active Ingredient Solutions
Fermion Oy
P&R SpA
SIMS Srl
Egis Pharmaceuticals PLC
Xian Hench Biotechnology
Orion
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Sodium Cromoglicate API product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Sodium Cromoglicate API, with price, sales quantity, revenue, and global market share of Sodium Cromoglicate API from 2020 to 2025.
Chapter 3, the Sodium Cromoglicate API competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Sodium Cromoglicate API breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Sodium Cromoglicate API market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Sodium Cromoglicate API.
Chapter 14 and 15, to describe Sodium Cromoglicate API sales channel, distributors, customers, research findings and conclusion.
Summary:
Get latest Market Research Reports on Sodium Cromoglicate API. Industry analysis & Market Report on Sodium Cromoglicate API is a syndicated market report, published as Global Sodium Cromoglicate API Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031. It is complete Research Study and Industry Analysis of Sodium Cromoglicate API market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.